| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Larissa Silva de Lima, Vinícius Loyola, João Victor Montenegro Luzardo Bicca, Lucas Faro, Camilla Lepesqueur Costa Vale, Bruna Lotufo Denucci, Márcia Renata Mortar. Innovative treatments for epilepsy: Venom peptides, cannabinoids, and neurostimulation. Journal of neuroscience research. 2022-08-08. PMID:35934922. |
innovative treatments for epilepsy: venom peptides, cannabinoids, and neurostimulation. |
2022-08-08 |
2023-08-14 |
Not clear |
| Larissa Silva de Lima, Vinícius Loyola, João Victor Montenegro Luzardo Bicca, Lucas Faro, Camilla Lepesqueur Costa Vale, Bruna Lotufo Denucci, Márcia Renata Mortar. Innovative treatments for epilepsy: Venom peptides, cannabinoids, and neurostimulation. Journal of neuroscience research. 2022-08-08. PMID:35934922. |
other options are cannabinoids and compounds that modulate the endocannabinoid system, since it is now known that this network is involved in the pathophysiology of epilepsy. |
2022-08-08 |
2023-08-14 |
Not clear |
| Moneeza Abbas, Shabnum Shaheen, Amina Arshad, Muhammad Ali, Bilal Rasool, Ghulam Rasoo. Comparative light and scanning electron microscopic studies of pollen of two marijuana species causing allergies. Microscopy research and technique. 2022-06-06. PMID:35661329. |
this plant is a great natural source of cannabinoids, which have several medical applications such as it is used for the treatment of anxiety and psychosis, disorders of motility and epilepsy. |
2022-06-06 |
2023-08-14 |
Not clear |
| Alessandro Papa, Silvia Pasquini, Chiara Contri, Sandra Gemma, Giuseppe Campiani, Stefania Butini, Katia Varani, Fabrizio Vincenz. Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition. Cells. vol 11. issue 3. 2022-02-15. PMID:35159280. |
the endocannabinoid system (ecs) is emerging as a particularly attractive therapeutic target in cns disorders and neurodegenerative diseases including parkinson's disease (pd), alzheimer's disease (ad), huntington's disease (hd), multiple sclerosis (ms), amyotrophic lateral sclerosis (als), stroke, traumatic brain injury (tbi), pain, and epilepsy. |
2022-02-15 |
2023-08-13 |
Not clear |
| Yuki Sugaya, Masanobu Kan. Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures. Frontiers in neural circuits. vol 15. 2022-01-20. PMID:35046779. |
application of cannabinoid sensors to epilepsy research has elucidated activity-dependent changes in endocannabinoid signaling during seizures. |
2022-01-20 |
2023-08-13 |
Not clear |
| Cristina Ferreira Almeida, Natércia Teixeira, Georgina Correia-da-Silva, Cristina Amara. Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype. Molecules (Basel, Switzerland). vol 27. issue 1. 2022-01-11. PMID:35011388. |
indeed, it is well established that cannabinoids exert important actions on multiple sclerosis, epilepsy and pain relief. |
2022-01-11 |
2023-08-13 |
Not clear |
| Jon Egaña-Huguet, Edgar Soria-Gómez, Pedro Grande. The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models. International journal of molecular sciences. vol 22. issue 24. 2021-12-24. PMID:34948035. |
the endocannabinoid system in glial cells and their profitable interactions to treat epilepsy: evidence from animal models. |
2021-12-24 |
2023-08-13 |
human |
| Jon Egaña-Huguet, Edgar Soria-Gómez, Pedro Grande. The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models. International journal of molecular sciences. vol 22. issue 24. 2021-12-24. PMID:34948035. |
the neuroprotective and therapeutic effect of (endo)cannabinoid compounds has been extensively investigated in several models of epilepsy. |
2021-12-24 |
2023-08-13 |
human |
| Jon Egaña-Huguet, Edgar Soria-Gómez, Pedro Grande. The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models. International journal of molecular sciences. vol 22. issue 24. 2021-12-24. PMID:34948035. |
however, little is known about the impact of the endocannabinoid system (ecs) regulation over glial cells, even less in pathological conditions such as epilepsy. |
2021-12-24 |
2023-08-13 |
human |
| Jon Egaña-Huguet, Edgar Soria-Gómez, Pedro Grande. The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models. International journal of molecular sciences. vol 22. issue 24. 2021-12-24. PMID:34948035. |
thus, we propose that glial cells could be a novel target for cannabinoid agents for treating the etiology of epilepsy and managing seizure-like disorders. |
2021-12-24 |
2023-08-13 |
human |
| Christopher Martínez-Aguirre, Resat Cinar, Luisa Roch. Targeting endocannabinoid system in epilepsy: for good or for bad. Neuroscience. 2021-12-19. PMID:34923038. |
targeting endocannabinoid system in epilepsy: for good or for bad. |
2021-12-19 |
2023-08-13 |
Not clear |
| Christopher Martínez-Aguirre, Resat Cinar, Luisa Roch. Targeting endocannabinoid system in epilepsy: for good or for bad. Neuroscience. 2021-12-19. PMID:34923038. |
several studies carried out during the last decades indicate that the administration of cannabinoids as well as the activation of the endocannabinoid system (ecs) represent a therapeutic strategy to control epilepsy. |
2021-12-19 |
2023-08-13 |
Not clear |
| Payam Sazega. Cannabis Essentials: Tools for Clinical Practice. American family physician. vol 104. issue 6. 2021-12-16. PMID:34913644. |
current evidence supports cannabinoid use only for a limited number of conditions (chemotherapy-induced nausea and vomiting, specific pain and spasticity syndromes, and certain forms of childhood epilepsy); thus, physicians recommending cannabinoids need to weigh the potential harms vs. perceived benefits. |
2021-12-16 |
2023-08-13 |
Not clear |
| C Espinosa-Jove. Cannabinoids in epilepsy: clinical efficacy and pharmacological considerations. Neurologia (Barcelona, Spain). 2021-11-26. PMID:34824031. |
cannabinoids in epilepsy: clinical efficacy and pharmacological considerations. |
2021-11-26 |
2023-08-13 |
Not clear |
| Aviv Amirav, Benny Neumark, Ksenia J Margolin Eren, Alexander B Fialkov, Noam Ta. Cannabis and its cannabinoids analysis by gas chromatography-mass spectrometry with Cold EI. Journal of mass spectrometry : JMS. vol 56. issue 6. 2021-11-15. PMID:33955098. |
finally, cannabis drugs such as ep-1 used in israel for treatment of epilepsy and for children with autism spectrum disorder (asd) were analyzed for their full cannabinoids content for learning on the entourage effect and for drug activity optimization. |
2021-11-15 |
2023-08-13 |
Not clear |
| Bao Xue, Xia Zhang, Ying Wan. Bench to bedside: Multiple facets of cannabinoid control in epilepsy. Neurochemistry international. vol 141. 2021-10-18. PMID:33159980. |
bench to bedside: multiple facets of cannabinoid control in epilepsy. |
2021-10-18 |
2023-08-13 |
Not clear |
| Bao Xue, Xia Zhang, Ying Wan. Bench to bedside: Multiple facets of cannabinoid control in epilepsy. Neurochemistry international. vol 141. 2021-10-18. PMID:33159980. |
endocannabinoid system, the critical regulator of synaptic inhibition in brain, was supposed to be closely involved in epilepsy. |
2021-10-18 |
2023-08-13 |
Not clear |
| Bao Xue, Xia Zhang, Ying Wan. Bench to bedside: Multiple facets of cannabinoid control in epilepsy. Neurochemistry international. vol 141. 2021-10-18. PMID:33159980. |
therefore, we review recent advances from bench to bedside, to address the cannabinoid control on seizures, discuss the existing confusion in current studies and provide directions for further research, which may be clinically important for the design of cannabinoid-based precise therapeutic interventions for epilepsy. |
2021-10-18 |
2023-08-13 |
Not clear |
| Laila Asth, Lia P Iglesias, Antônio C De Oliveira, Marcio F D Moraes, Fabrício A Moreir. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment. Epilepsy & behavior : E&B. vol 121. issue Pt B. 2021-08-11. PMID:31839498. |
exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment. |
2021-08-11 |
2023-08-13 |
Not clear |
| Laila Asth, Lia P Iglesias, Antônio C De Oliveira, Marcio F D Moraes, Fabrício A Moreir. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment. Epilepsy & behavior : E&B. vol 121. issue Pt B. 2021-08-11. PMID:31839498. |
this review focuses on the possible roles of phytocannabinoids, synthetic cannabinoids, endocannabinoids, and "transient receptor potential cation channel, subfamily v, member 1" (trpv1) channel blockers in epilepsy treatment. |
2021-08-11 |
2023-08-13 |
Not clear |